Listen Live

Current Weather

Loading advertisement…

Canada approves second generic version of Ozempic

OTTAWA, May 1 (Reuters) - The Canadian health regulator said on Friday that it had approved Canada-based Apotex's generic version of semaglutide, making it the second copycat version of Danish drugmaker Novo Nordisk's blockbuster diabetes drug Ozempic authorized in the country. (Reporting by Ismail... Read More.